ASC/TERT12024-01-02T09:47:50+00:00

Adipose tissue

ASC/TERT1

Evercyte ́s human adipose-derived mesenchymal stromal cell line ASC/TERT1 can be grown without limitations while maintaining expression of cell type specific markers and functions. The cells are characterized by self-renewal and multipotent differentiation capacity. Therefore, the cell line is a relevant and standardizible in vitro model to study processes such as differentiation, inflammation as well as tissue homeostasis and repair.

Print Friendly, PDF & Email

from

€ 1600,–

ASC/TERT1
Cat#: CHT-001-0005

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

“We have been using ASC/TERT1 since years for chondrogenic differentiation in in vitro as well as in vivo experiments. They are a valuable tool for avoiding donor variability allow for clearer and more constant results which is especially important for initial screenings or animal studies.”

 

Sylvia Nürnberger,

Principal investigator, Medical University of Vienna, Austria

 

Good cell culture practice / GCCP

get ready to standardize your cell culture work

production of spheroids from ASC/TERT1

standardized production of spheroids for tissue engineering

new cell factory for exosome production

human adipose-derived mesenchymal stem cell line ASC/TERT300 qualifies for production of clinical grade extracellular vesicles

ASC/TERT1 cells supporting vascularization of endothelial cells on novel hydrogel chips

all about
our exosomes

Cell factory for EV production

ASC/TERT300

human adipose-derived mesenchymal stem cells for production of clinical grade extracellular vesicles – coming soon

Related Services

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

“We have been using ASC/TERT1 since years for chondrogenic differentiation in in vitro as well as in vivo experiments. They are a valuable tool for avoiding donor variability allow for clearer and more constant results which is especially important for initial screenings or animal studies.”

 

Sylvia Nürnberger, principal investigator, Medical University of Vienna, Austria

Good cell culture practice / GCCP

get ready to standardize your cell culture work

Production of spheroids from ASC/TERT1

standardized production of spheroids for tissue engineering

Related Services

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

“We have been using ASC/TERT1 since years for chondrogenic differentiation in in vitro as well as in vivo experiments. They are a valuable tool for avoiding donor variability allow for clearer and more constant results which is especially important for initial screenings or animal studies.”

 

Sylvia Nürnberger, principal investigator, Medical University of Vienna, Austria

Good cell culture practice / GCCP

get ready to standardize your cell culture work

production of spheroids from ASC/TERT1

standardized production of spheroids for tissue engineering

new cell factory for exosome production

human adipose-derived mesenchymal stem cell line ASC/TERT300 qualifies for production of clinical grade extracellular vesicles

Wharton´s Jelly-derived MSCs for production of EVs

all about
our exosomes

Tissue targeting

engineering of CD81 on EVs to target specific cell surface proteins

Cell factory for EV production

ASC/TERT300

human adipose-derived mesenchymal stem cells for production of clinical grade extracellular vesicles – coming soon

New cell factory for extracellular vesicles production

Human adipose-derived mesenchymal stromal cell line ASC/TERT300 qualifies for production of clinical grade extracellular vesicles

Wharton´s Jelly-derived MSCs for production of EVs

All about
our EVs

Tissue targeting

engineering of CD81 on EVs to target specific cell surface proteins

Cell factory for EV production

ASC/TERT300

human adipose-derived mesenchymal stem cells for production of clinical grade extracellular vesicles – coming soon

Print Friendly, PDF & Email

from

€ 1300,–

ASC/TERT1
Cat#: CHT-001-0005

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Print Friendly, PDF & Email
Print Friendly, PDF & Email

from

€ 1300,–

ASC/TERT1
Cat#: CHT-001-0005

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Print Friendly, PDF & Email

Title

Go to Top